vs
艾伯维（ABBV）与Owlet, Inc.（OWLT）财务数据对比。点击上方公司名可切换其他公司
艾伯维的季度营收约是Owlet, Inc.的625.8倍（$16.6B vs $26.6M）。艾伯维净利率更高（10.9% vs -34.6%，领先45.5%）。Owlet, Inc.同比增速更快（29.6% vs 10.0%）。艾伯维自由现金流更多（$4.9B vs $-651.0K）。过去两年Owlet, Inc.的营收复合增速更高（34.2% vs 16.2%）
艾伯维是一家总部位于美国伊利诺伊州北芝加哥的制药企业，专注于研发、生产覆盖多种疾病领域的治疗药物，致力于为全球各地患者提供安全有效的临床解决方案，在全球医药行业拥有较高的知名度与影响力。
Owlet, Inc.是一家专注于儿科健康科技的企业，核心产品为可穿戴婴儿智能监测袜，可实时追踪婴幼儿心率、血氧水平及睡眠数据，产品通过自营电商和零售合作伙伴销往全球多个市场，为新手父母提供育儿健康支持。
ABBV vs OWLT — 直观对比
营收规模更大
ABBV
是对方的625.8倍
$26.6M
营收增速更快
OWLT
高出19.6%
10.0%
净利率更高
ABBV
高出45.5%
-34.6%
自由现金流更多
ABBV
多$4.9B
$-651.0K
两年增速更快
OWLT
近两年复合增速
16.2%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $16.6B | $26.6M |
| 净利润 | $1.8B | $-9.2M |
| 毛利率 | 72.6% | 47.6% |
| 营业利润率 | 27.3% | -18.4% |
| 净利率 | 10.9% | -34.6% |
| 营收同比 | 10.0% | 29.6% |
| 净利润同比 | 8354.5% | -1.5% |
| 每股收益（稀释后） | $1.02 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABBVOWLT
| Q4 25 | $16.6B | $26.6M | ||
| Q3 25 | $15.8B | $32.0M | ||
| Q2 25 | $15.4B | $26.1M | ||
| Q1 25 | $13.3B | $21.1M | ||
| Q4 24 | $15.1B | $20.5M | ||
| Q3 24 | $14.5B | $22.1M | ||
| Q2 24 | $14.5B | $20.7M | ||
| Q1 24 | $12.3B | $14.8M |
净利润ABBVOWLT
| Q4 25 | $1.8B | $-9.2M | ||
| Q3 25 | $186.0M | $4.1M | ||
| Q2 25 | $938.0M | $-37.6M | ||
| Q1 25 | $1.3B | $3.0M | ||
| Q4 24 | $-22.0M | $-9.1M | ||
| Q3 24 | $1.6B | $-5.6M | ||
| Q2 24 | $1.4B | $-1.1M | ||
| Q1 24 | $1.4B | $3.3M |
毛利率ABBVOWLT
| Q4 25 | 72.6% | 47.6% | ||
| Q3 25 | 66.4% | 50.6% | ||
| Q2 25 | 71.8% | 51.3% | ||
| Q1 25 | 70.0% | 53.7% | ||
| Q4 24 | 70.9% | 53.5% | ||
| Q3 24 | 70.9% | 52.2% | ||
| Q2 24 | 70.9% | 49.5% | ||
| Q1 24 | 66.7% | 44.4% |
营业利润率ABBVOWLT
| Q4 25 | 27.3% | -18.4% | ||
| Q3 25 | 12.1% | 3.8% | ||
| Q2 25 | 31.7% | -7.4% | ||
| Q1 25 | 28.0% | -12.7% | ||
| Q4 24 | -9.9% | -36.2% | ||
| Q3 24 | 26.5% | -21.8% | ||
| Q2 24 | 27.6% | -10.8% | ||
| Q1 24 | 22.7% | -39.0% |
净利率ABBVOWLT
| Q4 25 | 10.9% | -34.6% | ||
| Q3 25 | 1.2% | 12.9% | ||
| Q2 25 | 6.1% | -144.4% | ||
| Q1 25 | 9.6% | 14.3% | ||
| Q4 24 | -0.1% | -44.2% | ||
| Q3 24 | 10.8% | -25.4% | ||
| Q2 24 | 9.5% | -5.5% | ||
| Q1 24 | 11.1% | 22.2% |
每股收益（稀释后）ABBVOWLT
| Q4 25 | $1.02 | — | ||
| Q3 25 | $0.10 | $-0.06 | ||
| Q2 25 | $0.52 | $-2.37 | ||
| Q1 25 | $0.72 | $0.11 | ||
| Q4 24 | $-0.03 | $-0.15 | ||
| Q3 24 | $0.88 | $-0.61 | ||
| Q2 24 | $0.77 | $-0.30 | ||
| Q1 24 | $0.77 | $-0.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.3B | $35.5M |
| 总债务越低越好 | $58.9B | — |
| 股东权益账面价值 | $-3.3B | $19.0M |
| 总资产 | $134.0B | $85.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ABBVOWLT
| Q4 25 | $5.3B | $35.5M | ||
| Q3 25 | $5.7B | $23.8M | ||
| Q2 25 | $6.5B | $21.8M | ||
| Q1 25 | $5.2B | $16.3M | ||
| Q4 24 | $5.6B | $20.2M | ||
| Q3 24 | $7.3B | $21.6M | ||
| Q2 24 | $13.2B | $15.4M | ||
| Q1 24 | $18.1B | $18.4M |
总债务ABBVOWLT
| Q4 25 | $58.9B | — | ||
| Q3 25 | $63.0B | — | ||
| Q2 25 | $63.0B | — | ||
| Q1 25 | $64.5B | — | ||
| Q4 24 | $60.3B | — | ||
| Q3 24 | $58.5B | — | ||
| Q2 24 | $58.0B | $2.1M | ||
| Q1 24 | $63.8B | $4.0M |
股东权益ABBVOWLT
| Q4 25 | $-3.3B | $19.0M | ||
| Q3 25 | $-2.6B | $-54.1M | ||
| Q2 25 | $-183.0M | $-59.2M | ||
| Q1 25 | $1.4B | $-25.8M | ||
| Q4 24 | $3.3B | $-29.8M | ||
| Q3 24 | $6.0B | $-21.5M | ||
| Q2 24 | $6.8B | $-33.4M | ||
| Q1 24 | $8.0B | $-32.9M |
总资产ABBVOWLT
| Q4 25 | $134.0B | $85.6M | ||
| Q3 25 | $133.9B | $74.9M | ||
| Q2 25 | $137.2B | $63.5M | ||
| Q1 25 | $136.2B | $51.4M | ||
| Q4 24 | $135.2B | $49.5M | ||
| Q3 24 | $143.4B | $56.1M | ||
| Q2 24 | $141.9B | $45.9M | ||
| Q1 24 | $148.9B | $43.8M |
负债/权益比ABBVOWLT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 45.44× | — | ||
| Q4 24 | 18.15× | — | ||
| Q3 24 | 9.70× | — | ||
| Q2 24 | 8.56× | — | ||
| Q1 24 | 7.97× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.2B | $-452.0K |
| 自由现金流经营现金流 - 资本支出 | $4.9B | $-651.0K |
| 自由现金流率自由现金流/营收 | 29.4% | -2.5% |
| 资本支出强度资本支出/营收 | 2.0% | 0.7% |
| 现金转化率经营现金流/净利润 | 2.87× | — |
| 过去12个月自由现金流最近4个季度 | $17.8B | $-11.1M |
8季度趋势，按日历期对齐
经营现金流ABBVOWLT
| Q4 25 | $5.2B | $-452.0K | ||
| Q3 25 | $7.0B | $-2.2M | ||
| Q2 25 | $5.2B | $-2.2M | ||
| Q1 25 | $1.6B | $-5.9M | ||
| Q4 24 | $7.0B | $3.0M | ||
| Q3 24 | $5.4B | $-7.5M | ||
| Q2 24 | $2.3B | $-3.4M | ||
| Q1 24 | $4.0B | $-3.4M |
自由现金流ABBVOWLT
| Q4 25 | $4.9B | $-651.0K | ||
| Q3 25 | $6.6B | $-2.2M | ||
| Q2 25 | $4.9B | $-2.3M | ||
| Q1 25 | $1.4B | $-5.9M | ||
| Q4 24 | $6.8B | $3.0M | ||
| Q3 24 | $5.2B | $-7.5M | ||
| Q2 24 | $2.0B | $-3.4M | ||
| Q1 24 | $3.8B | — |
自由现金流率ABBVOWLT
| Q4 25 | 29.4% | -2.5% | ||
| Q3 25 | 42.1% | -6.8% | ||
| Q2 25 | 31.7% | -8.8% | ||
| Q1 25 | 10.5% | -28.1% | ||
| Q4 24 | 44.7% | 14.5% | ||
| Q3 24 | 35.9% | -33.9% | ||
| Q2 24 | 14.0% | -16.3% | ||
| Q1 24 | 31.3% | — |
资本支出强度ABBVOWLT
| Q4 25 | 2.0% | 0.7% | ||
| Q3 25 | 2.4% | 0.0% | ||
| Q2 25 | 1.7% | 0.2% | ||
| Q1 25 | 1.8% | 0.0% | ||
| Q4 24 | 1.9% | 0.2% | ||
| Q3 24 | 1.7% | 0.0% | ||
| Q2 24 | 1.7% | 0.0% | ||
| Q1 24 | 1.6% | 0.0% |
现金转化率ABBVOWLT
| Q4 25 | 2.87× | — | ||
| Q3 25 | 37.76× | -0.52× | ||
| Q2 25 | 5.49× | — | ||
| Q1 25 | 1.27× | -1.96× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.49× | — | ||
| Q2 24 | 1.66× | — | ||
| Q1 24 | 2.95× | -1.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABBV
暂无分部数据
OWLT
| US | $22.7M | 85% |
| Non Us | $3.2M | 12% |
| Other | $651.0K | 2% |
